Advertisement

Topics

"Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer" Drugs and Medication Database

16:47 EST 17th February 2019 | BioPortfolio

Here are the most relevant "Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer" Drugs and Medications that we have found in our database.

More Information about "Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer" on BioPortfolio

We have published hundreds of Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer news stories on BioPortfolio along with dozens of Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer Clinical Trials and PubMed Articles about Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer Companies in our database. You can also find out about relevant Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer Drugs and Medications on this site too.

Showing "Monoclonal Antibody A1G4 Plus Treating Patients With Cancer" Drugs and Medications 1–25 of 142

Possibly Relevant

Zinplava [merck sharp & dohme corp.]

These highlights do not include all the information needed to use ZINPLAVA safely and effectively. See full prescribing information for ZINPLAVA. ZINPLAVA™ (bezlotoxumab) injection, for intravenous use Initial U.S. Approval: 2016

Campath [genzyme corporation]

These highlights do not include all the information needed to use CAMPATH safely and effectively. See full prescribing information for CAMPATH. CAMPATH (alemtuzumab) Injection for intravenous useInitial U.S. Approval: 2001

Aimovig [amgen inc]

These highlights do not include all the information needed to use AIMOVIG safely and effectively. See full prescribing information for AIMOVIG. AIMOVIG (erenumab-aooe) injection, for subcutaneous use Initial U.S. Approval: 2018

Ajovy [teva pharmaceuticals usa, inc.]

These highlights do not include all the information needed to use AJOVY safely and effectively. See full prescribing information for AJOVY.AJOVY (fremanezumab-vfrm) injection, for subcutaneous useInitial U.S. Approval: 2018

Emgality [eli lilly and company]

These highlights do not include all the information needed to use EMGALITY safely and effectively. See full prescribing information for EMGALITY.EMGALITY (galcanezumab-gnlm) injection, for subcutaneous useInitial U.S. Approval: 2018

Fasenra [astrazeneca pharmaceuticals lp]

These highlights do not include all the information needed to use FASENRA safely and effectively. See full prescribing information for FASENRA.FASENRA (benralizumab) injection, for subcutaneous useInitial U.S. Approval: 2017

Yervoy [e.r. squibb & sons, l.l.c.]

These highlights do not include all the information needed to use YERVOY safely and effectively. See full prescribing information for YERVOY. YERVOY (ipilimumab) injection, for intravenous useInitial U.S. Approval: 2011

Prostascint kit for the preparation of indium in 111 capromab pendetide [jazz pharmaceuticals, inc.]

ProstaScintKit (capromab pendetide) Kit for the Preparation of Indium In 111 Capromab Pendetide For Intravenous Use Only

Sylvant [janssen biotech, inc.]

These highlights do not include all the information needed to use SYLVANT safely and effectively. See full prescribing information for SYLVANT. SYLVANT (siltuximab) for injection, for intravenous use Initial U.S. Approval: 2014

Repatha [amgen usa inc.]

These highlights do not include all the information needed to use REPATHA safely and effectively. See full prescribing information for REPATHA .     REPATHA (evolocumab) injection, for subcutaneous use Initial U.S. Approval: 2015

Repatha [amgen inc]

These highlights do not include all the information needed to use REPATHA safely and effectively. See full prescribing information for REPATHA .     REPATHA (evolocumab) injection, for subcutaneous use Initial U.S. Approval: 2015

Praxbind [boehringer ingelheim pharmaceuticals, inc.]

These highlights do not include all the information needed to use PRAXBIND safely and effectively. See full prescribing information for PRAXBIND. PRAXBIND (idarucizumab) injection, for intravenous useInitial U.S. Approval: 2015

Takhzyro [dyax corp.]

These highlights do not include all the information needed to use TAKHZYRO™ safely and effectively. See full prescribing information for TAKHZYRO™. TAKHZYRO™ (lanadelumab-flyo) injection, for subcutaneous use.Initial U.S. Approval: 2018.

Gemcitabine hydrochloride [bluepoint laboratories]

These highlights do not include all the information needed to use Gemcitabine for Injection safely and effectively. See full prescribing information for Gemcitabine for Injection. Gemcitabine for injection, Powder, Lyophilized, For Solution For Intravenou

Gemcitabine [fresenius kabi usa, llc]

These highlights do not include all the information needed to use Gemcitabine for Injection, USP safely and effectively. See full prescribing information for Gemcitabine for Injection, USP. Gemcitabine for Injection, USP, Powder, Lyophilized, For Solution

Gemcitabine [fresenius kabi usa, llc]

These highlights do not include all the information needed to use GEMCITABINE FOR INJECTION, USP safely and effectively. See full prescribing information for GEMCITABINE FOR INJECTION, USP. GEMCITABINE FOR INJECTION, USP, Powder, Lyophilized, For Solution

Gemcitabine hydrochloride [gland pharma limited]

These highlights do not include all the information needed to use Gemcitabine for Injection, USP safely and effectively. See full prescribing information for Gemcitabine for Injection, USP.Gemcitabine for injection, USP, powder, lyophilized, for solution,

Gemcitabine [mylan institutional llc]

These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous infusion onlyMust Be Diluted Before Use.Init

Gemcitabine [bedford laboratories]

These highlights do not include all the information needed to use gemcitabine for injection safely and effectively. See full prescribing information for gemcitabine for injection. Gemcitabine For Injection,  Powder, Lyophilized, For Solution For Intraven

Gemcitabine [dr. reddy's laboratories limited ]

These highlights do not include all the information needed to used GEMCITABINE FOR INJECTION safely and effectively. See full prescribing information for GEMCITABINE FOR INJECTION. GEMCITABINE for injection, powder, lyophilized, for solution for intraveno

Trogarzo [theratechnologies inc.]

These highlights do not include all the information needed to use TROGARZO safely and effectively. See full prescribing information for TROGARZO. TROGARZO™ (ibalizumab-uiyk) injection, for intravenous use Initial U.S. Approval: [2018]

Synagis [medimmune, llc]

These highlights do not include all the information needed to use SYNAGIS safely and effectively. See full prescribing information for SYNAGIS. SYNAGIS (palivizumab) injection, for intramuscular useInitial U.S. Approval: 1998

Gemcitabine [hospira, inc.]

These highlights do not include all the information needed to use GEMCITABINE FOR INJECTION safely and effectively. See full prescribing information for GEMCITABINE FOR INJECTION.GEMCITABINE for injection, powder, lyophilized, for solution for intravenous

Gemcitabine [hospira, inc.]

These highlights do not include all the information needed to use GEMCITABINE FOR INJECTION safely and effectively. See full prescribing information for GEMCITABINE FOR INJECTION. GEMCITABINE for injection, powder, lyophilized, for solution for intravenou

Siliq [valeant pharmaceuticals north america llc]

These highlights do not include all the information needed to use SILIQ safely and effectively. See full prescribing information for SILIQ. SILIQ™ (brodalumab) injection, for subcutaneous useInitial U.S. Approval: 2017



Advertisement
Quick Search
Advertisement
Advertisement